AmCham Kazakhstan Healthcare Committee Held Quarterly Meeting Focused on Key Industry Priorities

On April 14, 𝗔𝗺𝗖𝗵𝗮𝗺 𝗞𝗮𝘇𝗮𝗸𝗵𝘀𝘁𝗮𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗖𝗼𝗺𝗺𝗶𝘁𝘁𝗲𝗲 held a productive quarterly meeting hosted by Johnson & Johnson Kazakhstan. We sincerely thank our hosts for welcoming members and supporting an open discussion.

Committee members reviewed key developments shaping Kazakhstan’s healthcare and pharmaceutical environment, including 𝗩𝗔𝗧 𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀, 𝗽𝗿𝗶𝗰𝗶𝗻𝗴 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗼𝘀𝗶𝘁𝗲 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀, 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝗰𝗰𝗲𝘀𝘀, 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 𝗺𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗼𝗿𝗽𝗵𝗮𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀, and exchanged updates on the given topics.

The discussion also focused on practical next steps to improve regulatory clarity, strengthen investment confidence, and support timely access to innovative treatments for patients.

If your company is interested in the above-mentioned issues, we welcome you to join the Healthcare Committee and contribute to future discussions.